[1] Yoon S H, Min I K, Ahn J G. Immunochromatography for the diagnosis of Mycoplasma pneumoniae infection:A systematic review and meta-analysis[J]. PLoS One, 2020, 15(3):e0230338. [2] 蔡玲利, 钟森. 肺炎支原体肺炎的研究进展[J]. 河北医药, 2022, 44(11):1726-1731. [3] Wang M, Li H Y, Yang J L, et al. Clinical efficacy enhancement of a Chinese herbal injection in the treatment of Mycoplasma pneumonia in children:A protocol of randomized controlled trial[J]. Medicine, 2021, 100(12):e25135. [4] 谢国栋, 邓倩烨, 时晨辉, 等. 低龄肺炎支原体肺炎患儿肺功能变化及HRCT表现特点分析[J]. 中国CT和MRI杂志, 2020, 18(10):34-36. [5] 郝云, 李奇玉. 小儿肺炎支原体感染诊断方法研究进展[J]. 临床军医杂志, 2019, 47(2):217-219. [6] 张远明, 谭榕辉, 朱盼, 等. 阿奇霉素联合红霉素治疗小儿支原体肺炎随机对照试验Meta分析[J]. 中国抗生素杂志, 2018, 43(2):238-248. [7] 唐秀娟. 阿奇霉素治疗小儿肺炎支原体肺炎的疗效分析[J]. 广西医学, 2007, 29(7):1026-1027. [8] 黄仕琼, 徐金玉, 陈建国. 小儿重症肺炎支原体肺炎应用小剂量甲泼尼龙辅助治疗的临床疗效及对患儿肺功能的影响[J]. 湖南师范大学学报(医学版), 2019, 16(6):79-82. [9] 胡亚美. 诸福棠实用儿科学[M]. 北京:人民卫生出版社, 2002. [10] 陆权. 儿童社区获得性肺炎管理指南(试行)(上)[J]. 中华儿科杂志, 2007, 45(2):83-90. [11] Kumar S, Kashyap B, Kumar S, et al. Diagnostic utility of serology and polymerase chain reaction for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in paediatric community-acquired lower respiratory tract infections[J]. Indian Journal of Medical Microbiology, 2020, 38(2):152-156. [12] Bi Y N, Ma Y, Zhuo J H, et al. Risk of Mycoplasma pneumoniae-related hepatitis in MP pneumonia pediatric patients:A predictive model construction and assessment[J]. BMC Pediatrics, 2021, 21(1):287-289. [13] Cheng C H, Wang J Y, Li H B, et al. Optimal atlas segmentation on CT images for diagnosis of pediatric Mycoplasma pneumonia[J]. Scientific Programming, 2021, 2021(8):1-8. [14] Lanata M M, Wang H Y, Everhart K, et al. Macrolide-resistant Mycoplasma pneumoniae infections in children, Ohio, USA[J]. Emerging Infectious Diseases, 2021, 27(6):1588-1597. [15] Dumke R, Rodriguez N. Use of different approaches for the culture-independent typing of Mycoplasma pneumoniae from two geographically distinct regions[J]. Journal of Microbiological Methods, 2021, 186(2):e106239. [16] 高虹, 薛红霞. 阿奇霉素联合糖皮质激素治疗儿童重症肺炎支原体肺炎的效果及对机体炎性因子的影响[J]. 临床误诊误治, 2020, 33(5):60-63. [17] 唐静宜, 王群, 吴松杰, 等. 不同疗程静脉注射阿奇霉素治疗儿童支原体肺炎的有效性与安全性Meta分析[J]. 中国药师, 2020, 23(1):97-100. [18] 孙建华, 赵雨芳, 叶君红. 糖皮质激素辅助治疗儿童重症肺炎支原体肺炎的临床研究[J]. 中国临床药理学杂志, 2021, 37(7):795-797, 801. [19] 聂晓伟. 阿奇霉素联合甲泼尼龙治疗小儿重症支原体肺炎对免疫功能的影响[J]. 宁夏医科大学学报, 2021, 43(7):697-701. [20] 詹平, 吕燕清, 刘发英, 等. 红霉素和阿奇霉素对肺炎支原体感染儿童血清应激指标水平以及肺功能的影响[J]. 临床肺科杂志, 2020, 25(5):707-710. [21] 李华浚, 陈啸洪, 章杭湖, 等. 阿奇霉素联合甲泼尼龙治疗肺炎支原体肺炎患儿的临床研究[J]. 中国临床药理学杂志, 2015, 31(10):771-773. |